Returns in Q2 were 9.6% (Gross) and 8.8% (Net) compared to the Russell 1000 Growth Index return of 17.8% and the S&P 500 ...

Discover Alector's latest breakthroughs in neurodegenerative disease therapies, including updates on Alzheimer's and Parkinson's programs.

Suppose you have the opportunity to invest in a project that will require a $100 investment today and pay out a single cash flow of $250 in year ...